Dongcheng Biochemicals Stages $110 Million IPO in Shenzhen

Yantai Dongcheng Biochemicals has completed a $110 million IPO on Shenzhen’s Small and Medium-Sized Enterprises Board. The main products from Dongcheng Biochemicals, which makes APIs and finished products, are heparin sodium and chondroitin sulphate, a dietary supplement that treats osteoarthritis. More details.... Stock Symbol: (SHE: 002675) Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});